Radiopharmaceuticals Market to Witness 10.02% CAGR Boom Through 2024-30

Home / Marketing / Radiopharmaceuticals Market to Witness 10.02% CAGR Boom Through 2024-30 – Latest MarkNtel Advisors Report

The latest report by MarkNtel Advisors, titled “Radiopharmaceuticals Market Report By Radioisotope (Technetium 99, Fluorine 18, Iodine 131, Gallium 68, Iodine 123, Others), By Indication (Oncology, Cardiology, Gastroenterology, Nephrology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals, Medical Imaging Centers) Others, and Region 2024-2030”, offers a comprehensive analysis of the industry, which comprises insights on the Radiopharmaceuticals Market research report.

What is the market outlook for Radiopharmaceuticals?

Must Read: Important TikTok Tricks You Should Try to Market Your Brand

The Radiopharmaceuticals Market size is estimated to grow at a CAGR of around 10.02% during the forecast period 2024-30.

For an in-depth analysis, you can request a sample copy of the report: https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html

Major Companies Operating in the Radiopharmaceuticals Industry:

Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.

Radiopharmaceuticals Market Report Segmentation:

By Radioisotope

-Technetium 99

-Fluorine 18

-Iodine 131

-Gallium 68

-Iodine 123

-Others (Yttrium 90, Indium 111, etc.)

By Indication

-Oncology

-Cardiology

-Gastroenterology

-Nephrology

-Others (Neuroendocrinology, Neurology, etc.)

By Type

-Diagnostic

-Therapeutic

By End User

-Hospitals

-Medical Imaging Centers

-Others (Specialty Clinics, Research Organizations, etc.)

Learn More About the Market Report – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html

Regional Insights:

· North America: US, Canada, Mexico

· Europe: Germany, The UK, France, Spain, Italy, Rest of Europe

· Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific

· South America: Brazil, Rest of South America

· Middle East & Africa: GCC, South Africa, Rest of MEA

Global Radiopharmaceuticals Market Opportunity: Enhancing Radiopharmaceuticals Efficiency with Artificial Intelligence (AI)

Worldwide, there is a shortage of radiologists, and those who are there are dealing with overwhelming workloads, often leading to burnout and compromising patient care. The shortage is expected to increase in the coming years. For instance, according to the Association of American Medical Colleges (AAMC), by 2033, there will be a shortage of up to 41,900 radiologists in the US. Hence, the utilization of AI-driven software in conjunction with radiopharmaceuticals tends to increase the efficiency and proficiency of overworked radiologists and would drive the radiopharmaceuticals market.

Also, along with the surge in the prevalence of cancer and other chronic diseases worldwide, the burden of the elderly population is increasing at an enormous rate. This would necessitate radiologists to utilize AI technology in combination with radiopharmaceuticals to get faster and more accurate results. Additionally, AI facilitates personalized treatment planning by leveraging vast amounts of patient data, thereby enhancing the treatment outcome, and increasing patient satisfaction.

Ask Analyst for Customization: https://www.marknteladvisors.com/query/request-customization/radiopharmaceuticals-market.html

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.